US Schedules Covid-19 Vaccines For Children Below Five Years - Moderna (NASDAQ:MRNA), Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX)

The U.S. government is preparing to launch vaccines for children below five in conjunction with educational and outreach efforts, pending approval by federal regulators, the Wall Street Journal reports.
The government looks to provide ten million initial doses as the virus spreads nationwide, leaving the parents anxious.
The vaccinations could begin by June 21, subject to the regulatory approval for Moderna, Inc MRNA, Pfizer, Inc PFE, and partner BioNTech SE BNTX.
Equal amounts of vaccines from Pfizer and Moderna will be available on approval.
Five million doses have been made available for preorders by states, community health centers, and pharmacies. Another five million doses will be made available for preorder.
The government aimed to make them available through public-health clinics, community health centers, pharmacies including children’s hospitals, health systems, and pop-up clinics at children’s museums.
Vaccination rates for children between 5 and 18 years trailed those for older people.
An FDA advisory committee will meet on June 14-15 to review the vaccination data, followed by a CDC review on June 17-18.
Price Action: MRNA shares traded higher by 1.25% at $150.38 in the premarket on the last check Thursday.
Image by x3 from Pixabay